People · Operator
Named in public records as an officer, director or promoter · active 2020–2023 · Biotechnology, Software / Tech, Other Health Care, Media & Content, Construction
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| GIO World Health Ltd | — | Biotechnology | Series D+ | $300.0M | $7.4B | 2022 |
| Renew Tech One Ltd | — | Software / Tech | Series D+ | $200.0M | $2.7B | 2023 |
| GIO World Health (Europe) Ltd | — | Biotechnology | Series D+ | $150.0M | $3.7B | 2022 |
| Gio World Health (Europe) Sa | — | Biotechnology | Series D+ | $150.0M | $3.7B | 2022 |
| GIO Blood Ltd | — | Other Health Care | Series B | $27.3M | $375.5M | 2022 |
| GIOGI Ltd | — | Biotechnology | Series B | $27.3M | $554.5M | 2022 |
| GIOCAN Ltd | — | Biotechnology | Series B | $24.5M | $498.6M | 2022 |
| GIODIA Ltd | — | Biotechnology | Series B | $24.5M | $498.6M | 2022 |
| GIOHEALTH Ltd | — | Biotechnology | Series B | $24.5M | $498.6M | 2022 |
| TKRS Entertainment Ltd | — | Media & Content | Series B | $18.5M | $246.2M | 2020 |
| Sci Le Mas | — | Construction | Seed | $2.5M | $13.3M | 2022 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.